TheBitCast

Business Of Biotech

Autor: Ben Comer

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.

Odcinki

  1. Translating A New Discovery Into A Novel Cancer Therapy With Grid Therapeutics' Ned Patz, M.D. – Business Of Biotech
  2. Bioprinting 3D Human Tissue To Discover And Test New Treatments With Viscient Bio's Keith Murphy – Business Of Biotech
  3. Investing In Tomorrow's CNS Breakthroughs With Breyer Capital's Bret Bostwick, M.D. – Business Of Biotech
  4. AI, China, And Biotech Investing With SR One's Simeon George, M.D. – Business Of Biotech
  5. Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding – Business Of Biotech
  6. Growing And Scaling A Radiopharmaceuticals Company With AdvanCell's Philina Lee, Ph.D. – Business Of Biotech
  7. Finding New Opportunities In Obesity With Moonwalk Bioscience's Alex Aravanis, M.D., Ph.D. – Business Of Biotech
  8. Biotech Finance And Investor Update With Independent Board Director Allan Shaw – Business Of Biotech
  9. Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig – Business Of Biotech
  10. Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka – Business Of Biotech
  11. Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil – Business Of Biotech
  12. Getting To A First Product Approval With Celcuity's Brian Sullivan – Business Of Biotech
  13. Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings – Business Of Biotech
  14. A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D. – Business Of Biotech
  15. Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D. – Business Of Biotech
  16. Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D. – Business Of Biotech
  17. BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin – Business Of Biotech
  18. BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D. – Business Of Biotech
  19. Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D. – Business Of Biotech
  20. Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho – Business Of Biotech
  21. Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D. – Business Of Biotech
  22. The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry – Business Of Biotech
  23. Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D. – Business Of Biotech
  24. Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane – Business Of Biotech
  25. Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D. – Business Of Biotech
  26. Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D. – Business Of Biotech
  27. From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D. – Business Of Biotech
  28. Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary – Business Of Biotech
  29. The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw – Business Of Biotech
  30. Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D. – Business Of Biotech